Holen Sie sich die Stockscreener-App
1.50
2.04%
0.03
Vorhandelsmarkt:
1.48
-0.02
-1.33%
Opko Health Inc Aktie (OPK) Neueste Nachrichten
OPKO Health, Inc. (OPK) Stock: An Under $5 Gem with Biggest Upside Potential - Yahoo Finance
12 Stocks Under $5 With Biggest Upside Potential - Insider Monkey
Here's Why You Should Retain OPKO Health Stock in Your Portfolio - MSN
Opko health CEO Phillip Frost buys $220,425 in common stock - MSN
OPKO Health : Immediate Report -January 18, 2025 at 06:29 am EST - Marketscreener.com
BioReference faces $704,349 fine for medically unnecessary blood tests - MSN
Opko health CEO Phillip Frost buys $220,425 in common stock By Investing.com - Investing.com Australia
Phillip Md Et Al Frost Purchases 150,000 Shares of OPKO Health, Inc. (NASDAQ:OPK) Stock - MarketBeat
BioReference Health and OPKO Health Agree to Pay $704,349 to Settle Allegations that they Billed the - U.S. Politics Today
BioReference Health, OPKO Health Settle False Claims Violations - Bloomberg Law
Opko health CEO Phillip Frost buys $740,850 in stock By Investing.com - Investing.com South Africa
Barclays PLC Acquires 329,870 Shares of OPKO Health, Inc. (NASDAQ:OPK) - MarketBeat
Opko health CEO Phillip Frost buys $740,850 in stock - Investing.com India
OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $740,000.00 in Stock - MarketBeat
Opko Health Engages Investors at J.P. Morgan Conference - TipRanks
OPKO Health (NASDAQ:OPK) Stock Rating Lowered by StockNews.com - MarketBeat
OPKO Health Announces Progress in EBV Vaccine Study, Stock Gains - MSN
OPKO Health, Inc.'s (NASDAQ:OPK) Share Price Could Signal Some Risk - Simply Wall St
OPKO Health to Present at the 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewswire
Opko Health stock buy rating reaffirmed, steady target on clinical trial - Investing.com Canada
OPKO Health's (OPK) "Buy" Rating Reiterated at HC Wainwright - MarketBeat
OPKO Health (NASDAQ:OPK) Upgraded by StockNews.com to "Hold" Rating - MarketBeat
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr - GlobeNewswire
OPKO Health’s ModeX Therapeutics Announces Epstein-Barr Virus Vaccine Candidate Enters Phase I Clinical Study in Collaboration with Merck - Yahoo Finance
OPKO Health (NASDAQ:OPK) Sees Unusually-High Trading VolumeHere's Why - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Stake Cut by Geode Capital Management LLC - MarketBeat
3 Stocks That Wall Street Insiders Can't Stop Buying - MSN
3 Stocks That Wall Street Insiders Can’t Stop Buying - sharewise
Opko Health Inc (OPK-Q) QuotePress Release - The Globe and Mail
OPKO Health, Inc. (NASDAQ:OPK) Short Interest Down 14.0% in December - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) Shares Sold by State Street Corp - MarketBeat
OPKO Health (NASDAQ:OPK) Downgraded to Sell Rating by StockNews.com - MarketBeat
OPKO Health delivers 57% gain after January Fair Value signal flags undervaluation - Investing.com Canada
Esoteric Testing Market is Set to Experience a Revolutionary Growth | Labcorp, Quest Diagnostics, OPKO Health - openPR
Connected Drug Delivery Devices Market is Dazzling Worldwide - openPR
OPKO Health (NASDAQ:OPK) Raised to Hold at StockNews.com - MarketBeat
OPKO Health, Inc. (NASDAQ:OPK) CEO Buys $198,750.00 in Stock - MarketBeat
Phillip Frost Buys Handful Of Shares In OPKO Health - Simply Wall St
Opko health CEO Phillip Frost buys $199,375 in stock By Investing.com - Investing.com South Africa
Opko health CEO Phillip Frost buys $199,375 in stock - Investing.com
Opko Health stock hits 52-week high of $1.75 amid growth - Investing.com Canada
2.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):